Screener
Edwards Lifesciences EW Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Goodwill | 1,819.6 | 1,768.6 |
| Other intangible assets, net | 1,227.9 | 1,128.2 |
| Deferred income taxes | 1,098.1 | 1,138.1 |
| Other assets (Note 2) | 738.9 | 730.2 |
| Total assets | $13,321.2 | $13,697.2 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $181.1 | $227.5 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edwards Lifesciences's deferred tax assets and other non-current assets?
- Edwards Lifesciences (EW) reported deferred tax assets and other non-current assets of $738.9M in Q1 2026.
- How has Edwards Lifesciences's deferred tax assets and other non-current assets changed year-over-year?
- Edwards Lifesciences's deferred tax assets and other non-current assets decreased by 0.5% year-over-year, from $742.7M to $738.9M.
- What is the long-term trend for Edwards Lifesciences's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Edwards Lifesciences's deferred tax assets and other non-current assets has grown at a 43.6% compound annual growth rate (CAGR), from $119.6M to $730.2M.
Ask your AI about Edwards Lifesciences's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude